Ticker

No recent analyst price targets found for AIAI.

Latest News for AIAI

AIAI Holdings' MediGuide Enters the State-of-the-Art Medicine Market With AI-Driven Innovation

Leveraging Advanced Diagnostics and Screenings to Provide Personalized Proactive Care DALLAS, TX / ACCESS Newswire / July 14, 2026 / AIAI Holdings Corporation (NASDAQ:AIAI) ("Ai2" or the "Company"), an AI-enabled diversified holding company utilizing Transformational AI (TAI) to enhance portfolio performance, today announced that its portfolio company, MediGuide, has launched a state of the art (SOTA) precision…

Accesswire • Jul 14, 2026
NetraMark Signs New Contract To Analyze Phase 2 Neurodegeneration Trial Data With Contract Research Organization Partner

New agreement is a significant commercial milestone and the Company's first with its contract research organization partner Agreement expands NetraMark's portfolio of AI-driven projects in central nervous system (CNS) disorders TORONTO, July 09, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a company developing advanced artificial…

GlobeNewsWire • Jul 9, 2026
AIAI Holdings' Constellation Network Launches Gate AI: Real-Time Security for AI Applications

AI security gateway delivering prompt injection protection, token cost reduction, and verified auditability through Constellation Digital Evidence DALLAS, TX / ACCESS Newswire / July 8, 2026 / AIAI Holdings Corporation (NASDAQ:AIAI) ("Ai2" or the "Company"), an AI-enabled diversified holding company utilizing Transformational AI (TAI) to enhance portfolio performance, today announced that its portfolio company,…

Accesswire • Jul 8, 2026
AIAI Holdings' MediGuide Launches Digital Platform

Digital Transformation Initiative Establishes Operational Foundation for Innovation in Diagnostics, Prevention and Precision Medicine DALLAS, TX / ACCESS Newswire / July 1, 2026 / AIAI Holdings Corporation (NASDAQ:AIAI) ("Ai2" or the "Company"), an AI-enabled diversified holding company utilizing Transformational AI (TAI) to enhance portfolio performance, today announced that its portfolio company, MediGuide…

Accesswire • Jul 1, 2026
NetraMark Signs New NetraAI Clinical Trial Analysis Agreement with Late-Stage Biopharmaceutical Company

TORONTO, June 29, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), an artificial intelligence (AI) company that is transforming clinical trials with AI powered precision analytics in the pharmaceutical industry, today announced that it has signed a new agreement with a biopharmaceutical company developing a late-stage central nervous system…

GlobeNewsWire • Jun 29, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for AIAI.

No House trades found for AIAI.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top